Decay rates of anti-HIV dideoxynucleotides in tissue culture systems: A simple correction for the effect of cell replication

Drug Metabolism and Disposition

Volumn 25, Issue 7, 1997, Pages 893-896

  Johns, David G ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2',3' DIDEOXYADENOSINE; DIDANOSINE; TRITIUM;

ARTICLE; CELL PROLIFERATION; CELL TRANSPORT; DRUG CLEARANCE; DRUG DEGRADATION; DRUG EFFECT; DRUG HALF LIFE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TRANSPORT KINETICS;

ADENOSINE TRIPHOSPHATE; ANTI-HIV AGENTS; CELLS, CULTURED; CULTURE TECHNIQUES; DEOXYADENINE NUCLEOTIDES; HALF-LIFE; HUMANS;

TRITIUM;

EID: 0030806971     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Y. Törnevik, B. Jacobsson, S. Britton, and S. Eriksson: Intracellular metabolism of 3′-azidothymidine in isolated human peripheral blood mononuclear cells. AIDS Res. Human Retroviruses 7, 751-759 (1991).
2. Z. Zhu, H.-T. Ho, M. J. Hitchcock, and J.-P. Sommadossi: Cellular pharmacology of 2′,3′-didehydro-2′,3′-dideoxythymidine (D4T) in human peripheral blood mononuclear cells. Biochem. Pharmacol. 39, R15-R19 (1990).
3. R. Yarchoan, H. Mitsuya, R. V. Thomas, J. M. Pluda, N. R. Hartman, C.-F. Perno, K. S. Marczyk, J.-P. Allain, D. G. Johns, and S. Broder: In vivo activity against HIV and favorable toxicity profile of 2′,3′-dideoxyinosine. Science 245, 412-415 (1989).
4. R. Musood, G. S. Ahluwalia, D. A. Cooney, A. Fridland, V. E. Marquez, J. S. Driscoll, Z. Hao, H. Mitsuya, C.-F. Perno, S. Broder, and D. G. Johns: Fluoro-2′,3′-dideoxyarabinosyladenine: a metabolically stable analogue of the antiretroviral agent 2′,3′-dideoxyadenosine. Mol. Pharmacol. 37, 590-596 (1990).
5. H.-T. Ho, K. L. Woods, M. Mansuri, and M. J. M. Hitchcock: Activation of 2′-fluoro-2′,3′-dideoxyarabinosyladenine (FddA), an anti-HIV agent, in both quiescent and PHA-activated human peripheral blood mononuclear cells (PBMC). Antiviral Res. 15 (Suppl. 1), 95 (1991).
6. A. Fridland, M. C. Connelly, and R. Ashmun: Relationship of deoxynucleotide changes to inhibition of DNA synthesis induced by the antiretroviral agent 3′-azido-3′-deoxythymidine and release of its monophosphate by human lymphoid cells (CCRF-CEM). Mol. Pharmacol. 37, 665-670 (1990).
7. D. A. Cooney, M. Dalai, H. Mitsuya, J. B. McMahon, M. Nadkarni, J. Balzarini, S. Broder, and D. G. Johns: Initial studies on the cellular pharmacology of 2′,3′-dideoxycytidine, an inhibitor of HTLV-III infectivity. Biochem. Pharmacol. 35, 2065-2068 (1986).
8. H.-T. Ho and M. J. M. Hitchcock: Cellular pharmacology of 2′,3′-dideoxy-2′,3′-didehydrothymidine, a nucleoside analog active against human immunodeficiency virus. Antimicrob. Agents Chemother. 33, 844-849 (1989).
9. N. Cammack, P. Rouse, C. L. P. Marr, P. J. Reid, R. E. Boehme, J. A. V. Coates, C. R. Penn, and J. M. Cameron: Cellular metabolism of (-)enantiomeric 2′-deoxy-3′-thiacytidine. Biochem. Pharmacol. 43, 2059-2064 (1992).
10. G. Ahluwalia, D. A. Cooney, N. R. Hartman, H. Mitsuya, R. Yarchoan, A. Fridland, S. Broder, and D. G. Johns: Anomalous accumulation and decay of 2′,3′-dideoxyadenosine-5′-triphosphate in human T-cell cultures exposed to the anti-HIV drug 2′,3′-dideoxyinosine. Drug Metab. Dispos. 21, 369-376 (1993).
11. L. L. Bondoc, Jr., G. Ahluwalia, D. A. Cooney, N. R. Hartman, D. G. Johns, and A. Fridland: Metabolic pathways for the activation of the antiviral agent 2′,3′-dideoxyguanosine in human lymphoid cells. Mol. Pharmacol. 42, 525-530 (1992).
12. Z. Hao, E. E. Stowe, G. Ahluwalia, D. C. Baker, A. K. Hebbler, C. Chisena, S. M. Musser, J. A. Kelley, C.-F. Perno, D. G. Johns, and D. A. Cooney: Characterization of 2′,3′-dideoxycytidine diphosphocholine and 2′,3′-dideoxycytidine diphosphoethanolamine. Drug Metab. Dispos. 21, 738-744 (1993).
13. R. L. Blakley, F. C. Harwood, and K. D. Huff: Cytostatic effects of 2′,3′-dideoxyribonucleosides on transformed human hemopoietic cell lines. Mol. Pharmacol. 37, 328-332 (1990).
14. M. J. M. Hitchcock, K. Woods, H. DeBoeck, and H.-T. Ho: Biochemical pharmacology of 2′-fluoro-2′,3′-dideoxyarabinosyladenine, an inhibitor of HIV with improved metabolic and chemical stability over 2′,3′-dideoxyadenosine. Antiviral Chem. Chemother. 1, 319-327 (1990).